September 12th,2020
Oncolytic therapy using recombinant measles virus was introduced in The Asahi Shimbun Globe＋
January 1st,2020
The Nipah Vaccine development project was introduced in the EMPower CLUB NETWORK
December 17th, 2019
Kai lab opening party at the Institute of Industrial Science
Kai lab has moved from the Institute of Medical Science campus to the Institute of Industrial Science campus in Sep, 2019. Lab has finished its set-up on the new location and we had an opening party to celebrate it.
Please see the details here.
September 30th, 2019
Institute of Industrial Science Open symposium, co-sponsored by CEPI
IIS Open Symposium, co-sponsored by CEPI was held at the University of Tokyo.
Please see the details here.
March 22nd, 2019
Memorial Lecture & Reception
Dr. Kai Chieko retired from professorship at the Laboratory Animal Research Center, the Institute of Medical Science, the University of Tokyo as of March 31st, 2019.
In commemoration of her retirement, memorial lecture and reception were held.
Please see the details here。
Feburary 25th, 2019
CEPI and The University of Tokyo annouonced a partnering agreement
CEPI awards contract worth up to US$31 million to The University of Tokyo to develop vaccine against Nipah virus.
Link to Nipah Vaccine Project
Link to Informational Release by UTokyo
Link to Informational Release by CEPI
May 24th, 2017
Our oncolytic virotherapy research was featured on Asahi newspaper
Our oncolytic virotherapy research using recombinant measles virus was featured in the Asahi newspaper.
October 7th, 2016
Dr. Fujiyuki has won the poster award at the 64th Annual Meeting of the Japanese Society for Virology (JSV)
Poster Title：
Recombinant SLAM-blind measles virus is a promising candidate for triple negative breast cancer therapy
For JSV website, see here
October 9-10th, 2016
Dr. Kai has given the invitation lecture at the 12th Annual Conference of Chinese Association fro Laboratory Animal Science.
January 17th, 2016
Our research was featured in the Nikkei Newspaper
Our research on the oncolytic virotherapy using recombinant measles vaccine was featured in the Scientific Technology section of Nekkei Newspaper.
October 4th, 2015
Our research was featured on Nekkei newspaper
A part of our research on Nipah virus vaccine was featured on the science section of Nikkei newspaper.
※Dr. Misako Yoneda is the model of the person in the picture.